Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma?

"Conflict of Interest Statement F.O. is a director and shareholder in Fibrofind Ltd. J.L. is a shareholder in Fibrofind Ltd, all other authors declare no competing interests."

"M.Y.W.Z. was supported by a personal award from the Newton-Mosharafa Fund and is currently funded by Newton prize 2020; S.F.A. was supported by a personal award from Damascus University; G.L.P. and the creation of the Newcastle University Gastroenterology Research Tissue Bank were supported by the European Community's Seventh Framework Program (FP7/2001–2013) under Grant agreement HEALTH-F2-2009-241762 for the project FLIP. H.L.R, D.T., A.W., H.T., G.S.B. were supported by Newcastle Cancer Research UK (CRUK) Experimental Cancer Medicine Centre award C9380/A18084. H.L.R., F.O., J.L. and M.L. were supported by the CRUK Accelerator award C9380/A26813 and CRUK programme Grant C18342/A23390. H.L.R., F.O., Q.M.A., M.Y.W.Z. and O.G. were supported by Horizon 2020 Framework Program of the European Union under Grant Agreement 634413 for the project EPOS. F.O. received Medical Research Council funding, program Grants MR/K0019494/1 and MR/R023026/1. D.G. is funded by the Newcastle CRUK Clinical Academic Training Programme."